Damage-induced SOS mutagenesis requiring the UmuDC proteins occurs as part of the cells' global response to DNA damage. In vitro studies on the biochemical basis of SOS mutagenesis have been hampered by difficulties in obtaining biologically active UmuC protein, which, when overproduced, is insoluble in aqueous solution. We have circumvented this problem by purifying the UmuD 2 C complex in soluble form and have used it to reconstitute an SOS lesion bypass system in vitro. Stimulated bypass of a site-directed model abasic lesion occurs in the presence of UmuD 2 C, activated RecA protein (RecA*), ␤-sliding clamp, ␥-clamp loading complex, single-stranded binding protein (SSB), and either DNA polymerases III or II. Synthesis in the presence of UmuD 2 C is nonprocessive on damaged and undamaged DNA. No lesion bypass is observed when wild-type RecA is replaced with RecA1730, a mutant that is specifically defective for Umu-dependent mutagenesis. Perhaps the most noteworthy property of UmuD 2 C resides in its ability to stimulate both nucleotide misincorporation and mismatch extension at aberrant and normal template sites. These observations provide a biochemical basis for the role of the Umu complex in SOS-targeted and SOS-untargeted mutagenesis.
Escherichia coli normally replicates its DNA accurately, but the fidelity of replication decreases dramatically after cells are exposed to a variety of DNA-damaging agents that induce the SOS response (1) (2) (3) . Given a choice, E. coli will evoke a damage avoidance pathway that in all likelihood involves polymerase strand switching to a nondamaged DNA template (4, 5) . Nevertheless, situations arise where the DNA replication machinery encounters a lesion and the only recourse is the direct replication of the damaged template.
Genetic characterization of the error-prone translesion DNA synthesis pathway shows that it depends on the UmuDЈ 2 C complex, activated RecA protein (RecA*) and DNA polymerase (pol) III (6) (7) (8) (9) (10) . A prevailing model for translesion DNA synthesis, based on genetic experiments, suggests that it can be separated into two steps: nucleotide misincorporation directly opposite the lesion, believed to require pol III and RecA (11, 12) , and lesion bypass believed to involve pol III and UmuDЈC proteins (12) (13) (14) .
A major roadblock in the path toward understanding the phenomenon of Umu-dependent translesion DNA synthesis has been the inability to purify biologically active UmuC. By using a denatured-renatured form of UmuC, Echols and colleagues (15) were able to purify UmuC and demonstrate that together with UmuDЈ and RecA*, DNA pol III was able to facilitate limited translesion DNA synthesis of a synthetic abasic site (16) . We recently have succeeded in purifying the native UmuDЈ 2 C complex directly, in soluble form (17) . We showed that this complex binds cooperatively to singlestranded DNA (17) , having similar affinities to damaged and undamaged DNA, and effectively blocks recombinational strand exchange in vitro (W. M. Rehrauer, I.B. R.W., M.F.G., and S. C. Kowalczykowski, unpublished data). In the present study, we use the soluble UmuDЈ 2 C complex to reconstitute an in vitro lesion bypass assay dependent on UmuDЈ 2 C and RecA*. A key finding is that in the presence of UmuDЈ 2 C, the fidelity of DNA synthesis is compromised markedly at both damaged and undamaged template sites, thus providing a framework for studying the biochemical mechanisms governing SOS targeted and untargeted mutagenesis.
MATERIALS AND METHODS

Materials.
The following reagents were all purchased: T4 polynucleotide kinase (United States Biochemical͞Amer-sham), T4 DNA ligase (Promega), EcoRI restriction enzyme (New England Biolabs), E. coli single-stranded binding protein (SSB; Pharmacia), ultrapure ATP and dideoxynucleoside triphosphates (Pharmacia), and [␥- 32 P]ATP (4000 Ci͞mmol; 1 Ci ϭ 37 GBq) (ICN). Purification of pol III and its accessory proteins (18) and pol II (19) were carried out as described. RecA protein and pol I antibody were generous gifts from Stephen Kowalczykowski (University of California, Davis) and Lawrence Loeb (University of Washington, Seattle), respectively. The abasic (1,4-anhydro-2-deoxy-D-ribitol) phosphoramimide was synthesized as described (20) .
Purification of UmuD 2 C Complex. Purification was carried out as reported (17) with the following modifications: after polyetheleneimine precipitation, proteins were extracted by stirring the pellet in R-buffer (20 mM Tris⅐HCl, pH 7.5͞0.1 mM EDTA͞1 mM DTT͞20% glycerol) containing 1 M NaCl. Ammonium sulfate was added to reach 50% of saturation, followed by centrifugation of the suspension. The pellet was dissolved in R-buffer containing 1 M NaCl, dialyzed against R-buffer with 1 M NaCl, followed by a second ammonium sulfate precipitation step in which UmuDЈ 2 C complex precipitated at 30% saturation. The spun pellet was again dissolved in R-buffer with 1 M NaCl and dialyzed against R-buffer containing 50 mM NaCl before chromatography using DEAE and phosphocellulose as described (17) . Phosphocellulose fractions containing UmuDЈ 2 C were concentrated and applied seperately onto either Superdex 75 (17), Sephadex G100, or Sephadex G150 columns (Pharmacia) and eluted in R-buffer containing 1 M NaCl, resulting in a purity of Ͼ95%.
Primer͞Template Construction. All oligonucleotides were synthesized on an Applied Biosystems model 392 DNA͞RNA synthesizer. The template used in the replicative bypass assay, a 7.2-kb linear single-stranded DNA with an abasic lesion located 50 bases from the 5Ј end, was constructed as described (16) . Two 5Ј-end 32 P-labeled 30-mers were used as primers. In the ''running-start'' assay, the first primer is annealed to the template such that its 3Ј end is 46 nt from the lesion. In the ''standing-start'' assay, the 3Ј end of the primer is located one base before the abasic lesion.
Replicative Bypass Assay. The reaction mixture (10 l) contains 20 mM Tris⅐HCl (pH 7.5), 8 mM MgCl 2 , 5 mM DTT, 0.1 mM EDTA, 25 mM sodium glutamate, 1 mM ATP, and 4% (vol͞vol) glycerol. Running-start reactions were performed as follows: 2 nM primed DNA substrate was incubated for 2 min at 37°C with 40 nM ␤ protein dimer, 10 nM ␥-complex, 1 M RecA, 200 nM UmuDЈ 2 C complex, and 100 M each of dATP and dCTP. SSB (300 nM as tetramer) was then added to the mixture and incubated for another 2 min. Replication was initiated by addition of dGTP and dTTP (100 M each) and either pol III core, pol III ␣-subunit, or pol II, at concentrations between 0 and 20 nM. Reactions were carried out at 37°C for 10 min, then quenched by adding 20 l EDTA (20 mM) in 95% formamide. The product DNA was heat denatured run on a 10% polyacrylamide denaturing gel. Replication products were quantitated by using a PhosphorImager (Molecular Dynamics). Standing-start reactions were carried out in a similar manner as running-start reactions, except that all four dNTPs were added after preincubation with UmuDЈ 2 C, RecA, SSB and ␤,␥-complex.
RESULTS
Studies on the biochemical basis of SOS-induced mutagenesis have been hampered by the absence of a reconstituted in vitro assay using purified lesion bypass proteins. We now report on the reconstitution of such an assay by using all of the components of the mutasome, UmuDЈ 2 C, RecA*, and pol III.
Reconstituting Lesion Bypass in Vitro By Using Purified UmuD 2 C, RecA, SSB, and Components of Pol III Holoenzyme. A linearized M13 DNA template containing a single, sitedirected abasic lesion was copied by using different combinations of pol III core, pol III accessory proteins (␤,␥-complex), RecA, SSB, and UmuDЈ 2 C (Fig. 1 Left) . The primer-template ( Fig. 1 Upper) was designed to permit loading of the ␤ processivity clamp by the ␥-complex (21) and to allow binding of UmuDЈ 2 C, RecA, and SSB (17) . Relatively weak, nonprocessive synthesis is catalyzed by pol III core alone (Fig. 1, lane  1) . In the presence of ␤,␥-complex plus SSB, synthesis by pol III core becomes much more processive, terminating one base before reaching the abasic site (Fig. 1, lane 2) . Addition of RecA, either to pol III core (Fig. 1, lane 3) or to pol III core, ␤,␥-complex, and SSB (Fig. 1, lane 4) stimulates each reaction, but primer elongation still terminates at the X ؊ 1 position, one base before the lesion.
The key observation is that addition of UmuDЈ 2 C enables significant bypass of the lesion, with continued synthesis to the end of the template (Fig. 1, lane 5) . The presence of an intense pause band at X ؊ 1 suggests that incorporation opposite the lesion is still rate limiting, although it is possible that this band could arise by excision of a nucleotide incorporated opposite the abasic site by the proofreading exonuclease of pol III core. The polymerization reaction leading up to the lesion and beyond is essentially nonprocessive in the presence of UmuDЈ 2 C (Fig. 1, lane 5) , although pol III and ␤,␥-complex are both present along with ATP. A summation of integrated band intensities beyond the lesion (summed from site X ؉ 1 to the end of the template) relative to the bands extended up to and including the lesion (summed from site 1 to X) shows that the amount of bypass observed after a 10 min incubation is Ϸ20%; i.e., the amount of lesion bypass corresponds to 20% of the total synthesis.
Either ATP or the nonhydrolyzable ATP analog adenosine 5Ј-[␥S]thiotriphosphate (ATP␥S) is required for lesion bypass (data not shown). ATP or ATP-[␥S] is needed in the reaction for loading ␤ on DNA by ␥-complex (22) , and also for binding RecA to DNA (23) , thus converting it to RecA*. ATP is hydrolyzed throughout the reaction, resulting in a reduction to 60% of its initial level after a 10-min reaction (data not shown).
To verify that the initial input concentration of ATP (1 mM) FIG. 1. UmuDЈ 2C-stimulated abasic site bypass. Standard polymerization reactions, using a running-start protocol, were carried out in the presence or absence of exogenous pol III core by using combinations of UmuDЈ 2C, RecA, ␤,␥-complex, and SSB. Four dNTPs (100 M) and ATP (1 mM) were present in all reactions. A 32 P-labeled primer was annealed to a DNA template containing an abasic lesion, X (top of figure) , and the replication products were separated in 10% denaturing polyacrylamide gels and visualized by phosphorimaging. Locations of the unextended primer band, abasic site (X), upstream site adjacent to the lesion (X ؊ 1), and the end of template are indicated on the right. Lane P contains the primer in the absence of proteins. Additions to the replication reaction mixtures are shown in the box at the top of the gel; ␤ ϩ ␥, represents the ␤-clamp processivity subunit of the pol III holoenzyme complex and the five protein ␥-clamp loading complex consisting of the subunits ␥, ␦, ␦Ј, , . is sufficient to sustain the conversion of RecA 3 RecA*, we added LexA protein to the reaction at 10 min and observed RecA*-mediated cleavage of LexA (data not shown).
Optimal stoichiometries for each of the mutasome components in catalyzing lesion bypass were determined to be: M13 DNA (2 nM), UmuDЈ 2 C (200 nM), RecA (1 M), pol III core (in a range of 1-10 nM), ␤-sliding clamp (40 nM), ␥-clamp loading complex (10 nM), SSB (300 nM as tetramer), ATP (1 mM). The conditions leading to efficient lesion bypass differ in two important ways from those previously reported by using renatured UmuC (16, 24) . First, a molar ratio of 26UmuDЈ͞ UmuC was required in the earlier study to observe a small amount of bypass compared with the physiologically correct value of 2 UmuDЈ͞UmuC found for the soluble UmuDЈ 2 C complex used in the current study. This 13-fold difference suggests that perhaps most of the renatured UmuC was not biologically active. Polyethylene glycol (PEG) was required to observe lesion bypass in the earlier study, perhaps as a crowding agent to concentrate UmuC at the site of the lesion. Our bypass assay is insensitive to PEG.
UmuD 2 C Catalyzes RecA*-Dependent Lesion Bypass in the Absence of Exogeneous Pol III Core. Unexpectedly, lesion bypass was observed to occur in a ''control'' reaction containing UmuDЈ 2 C, RecA, ␤,␥-complex, and SSB, in the absence of exogeneous pol III core (Fig. 1, lane 9) . Lesion bypass does not occur in the absence of either RecA (Fig. 1, lane 7) or ␤,␥-complex plus SSB (Fig. 1, lane 8) . However, one interesting difference in the gel band patterns is the appearance of two adjacent bands just before the lesion (at X ؊ 1) and directly opposite the abasic site (X) (Fig. 1, lanes 7 and 8) . Thus, a band corresponding to stable incorporation opposite the lesion persists in the absence of added pol III core (in contrast to the presence of pol III core, compare with Fig. 1, lanes 2-4) . Therefore, our UmuDЈ 2 C preparation contains a weak pol activity (Fig. 1, lane 6 ) which is stimulated in the presence of RecA (Fig. 1, lane 8) . We estimate that UmuDЈ 2 C is at least 95% pure, based on the absence of contaminating bands on silver-stained or Coomassie-stained polyacrylamide gels (data not shown). The presence of pol I contamination can be ruled out because primer extension is unaltered when polymerization occurs in the presence of a potent neutralizing pol I antibody (data not shown). However, we cannot rule out the presence of trace levels of either pol III or pol II, despite the fact that the UmuDЈ 2 C complex was purified by gel filtration. We have verified that the UmuDЈ 2 C complex migrates with an expected molecular mass of 70 kDa, indicating that it is unlikely to be directly bound to a pol. It is therefore much more likely that pol II, whose molecular mass is 89.9 kDa (25) , is present as a contaminating pol, rather than either pol III core (167.5 kDa) or pol III ␣-subunit (130 kDa) (26) . However, we cannot yet eliminate the possibility that UmuDЈ 2 C might itself contain an intrinsic, low fidelity, pol activity. UmuDЈ and C exhibit no significant sequence similarity to any of the known pols, although UmuC is weakly homologous to yeast Rev1, which incorporates dCMP opposite abasic sites (27) .
A strain of E. coli carrying the recA1730 mutation (S117F) is proficient for most of RecA's activities but is specifically defective for Umu-dependent mutagenesis (8, 10, 28) , probably because RecA1730 is unable to target the Umu proteins to lesion-containing DNA (29) . Although DNA synthesis continues to take place when wild-type RecA protein is replaced with purified RecA1730, bypass of the abasic lesion no longer occurs (Fig. 1, lane 10) . Instead, the primer is extended one base prior to the lesion, with a much smaller amount of incorporation occurring directly opposite the lesion. These data are in contrast to the lesion bypass promoted by wild-type RecA protein (Fig. 1, lanes 5 and 9) , but are consistent with the activity of RecA1730 in vivo (8, 10) , and in vitro (29) .
The Effect of Pol III and Pol II on Lesion Bypass. We have measured lesion bypass as a function of the concentration of three DNA pols, pols III, II, and ␣-subunit, in the presence of a fixed concentration of UmuDЈ 2 C (Fig. 2) . The primer 3Ј end is located one base before the abasic lesion allowing incorporation of a single nucleotide opposite X from a standing start (Fig. 2 Upper) .
In reactions containing UmuDЈ 2 C, preincubations were carried out for 4 min in the presence of ␤,␥-complex, SSB, ATP (1 mM) and two dNTPs, dCTP (100 M), and dATP (100 M). dCTP is present to protect against primer degradation by pol-associated exonuclease activity; dATP can be incorporated opposite X, but can only be extended by formation of downstream mispairs (see Fig. 3A, UmuDЈ 2 C panel, lane A) . After preincubation, the three pols were added, along with dTTP (100 M) and dGTP (100 M), in separate reactions. An increase in the amount of intermediate and full-length products occurs with increasing concentrations of pol in the presence of UmuDЈ 2 C (Fig. 2) . However, the fraction of primers extended opposite the lesion and beyond actually decreases from about 40% to roughly 25% as the concentrations of pol III core and pol II increase from 0 to 20 nM and 10 nM, respectively (Fig. 2) . The decrease in the fraction of extended primers is caused by pol III core and pol II proofreading occurring primarily at the lesion site (X) and at the downstream X ؉ 1 site (pol III core and pol II panels, lanes 3 and 4). In contrast, there is no reduction in gel band intensities at X and X ؉ 1 by using nonproofreading pol III ␣ (pol III ␣ panel, lanes 3 and 4), whereas the fraction of primers extended opposite and beyond the lesion increases rather than decreases (Fig. 2) .
Bypass in the absence of UmuDЈ 2 C increases as the levels of pol are increased. For the case of pol III core and ␣-subunit, a small amount of bypass is observed at 20 nM enzyme concentrations (Fig. 2, lane 7) , with barely detectable fulllength product DNA formed at 20 nM pol concentrations (Fig.  2) . A larger amount of full-length product is made by pol II. The key point to emphasize is that synthesis opposite the lesion and beyond is reduced significantly for all three pols when UmuDЈ 2 C is absent from the reaction (Fig. 2 , ϪUmuDЈ 2 C, lanes 5-7). In a reciprocal experiment, in which the concentration of UmuDЈ 2 C was varied (at fixed pol concentration), we observed an increase in bypass efficiencies as UmuDЈ 2 C concentration is increased, with maximum bypass occurring at a molar ratio of 100 UmuDЈ 2 C͞1 primer-template DNA (p͞t DNA) (data not shown). A shallow inhibition (Ϸ30%) in bypass occurs at higher concentrations of UmuDЈ 2 C in the range of 200 nM to 1 M, which is possibly caused by interactions taking place between UmuDЈ 2 C and RecA bound to DNA downstream of the replication fork (ref. 17; W. M. Rehrauer, I.B. R.W., M.F.G., and S. C. Kowalczykowski, unpublished data). The data in Fig. 2 demonstrate that UmuDЈ 2 C is able to stimulate incorporation opposite the lesion and the addition of one or more nucleotides beyond the lesion.
For ␣-subunit, the band intensities at X and X ؉ 1 (one base downstream from the lesion) remain constant as ␣ is varied between 0 and 20 nM (Fig. 2 , ␣-subunit panel, ϩ UmuDЈ 2 C lanes). Therefore, in the absence of the -exonuclease subunit, the incorporation at X and X ؉ 1 is essentially independent of pol concentration, depending primarily on the concentration of UmuDЈ 2 C. An increase in full-length product at increased levels of ␣ suggests that the pol displaces UmuDЈ 2 C and continues synthesis downstream from the lesion. A similar conclusion can be drawn from the data with pol III core, and also from experiments in which the pols and UmuDЈ 2 C are both present when the reaction is initiated by addition of all four dNTPs (data not shown).
UmuD 2 C-Stimulated Base Misincorporation and Mismatch Extension at Aberrant and Normal Template Sites.
A clear illustration of the marked reduction in pol fidelity in the presence of UmuDЈ 2 C is seen when incorporation at aberrant and normal template sites is carried out by using just one dNTP substrate (Fig. 3) . A standing-start protocol is used to measure incorporation at an abasic lesion, X (Fig. 3A) or at a normal template T (Fig. 3B) . All reactions contain RecA, ␤,␥-complex, SSB, and ATP (1 mM), and either pol III core, pol II, or UmuDЈ 2 C. The levels of pol III core (1 nM) and pol II (0.2 nM) were chosen to give similar (or greater) amounts of synthesis than UmuDЈ 2 C (200 nM, in the absence of exogeneous pol), on an undamaged DNA template with the four dNTPs present (Fig. 3B, compare lanes 4 for the three panels) .
There is essentially no stable incorporation catalyzed by pol III (1 nM) opposite X by using either a single dNTP or in the presence of all four dNTPs (a faint band is seen in lanes A and 4, representing a small incorporation of dAMP). For pol II (0.2 nM), faint bands are observed for incorporation of dGMP, dAMP, and dTMP, but not dCMP. Pol II catalyzes a small amount of full-length product in the presence of all four dNTPs, consistent with our previous demonstration that pol II can copy past abasic lesions with a substantially higher efficiency than pol III (30) .
Synthesis carried out with UmuDЈ 2 C in the presence of only dGTP or dATP substrates results in the incorporation of five consecutive G's or A's, whereas synthesis with either dTTP or dCTP results in the incorporation of either three T's or one C (Fig. 3A) . The results are similar in the presence or absence of exogenous pol (data not shown).
The first incorporation occurs opposite the abasic lesion. Synthesis taking place at template sites downstream from the lesion correspond mainly to the incorporation of mismatched nucleotides, followed by extension of mismatched termini and by additional misincorporations. A much larger amount of synthesis occurs in the presence of four dNTPs (Fig. 3A, lane  4) . The weak primer extension band observed in the absence of dNTPs (Fig. 3, UmuDЈ 2 C panel, lane 0) is caused by incorporation of ribo AMP. These results stand in marked contrast to the relatively weak primer extension catalyzed by pol III and pol II, in the absence of UmuDЈ 2 C, and clearly demonstrate the remarkable effect of UmuDЈ 2 C in relaxing the specificity of nucleotide incorporation at aberrant and normal template sites. Given the paucity of incorporation by pol III and pol II on the abasic template, it is important to show that these pols carry out normal DNA synthesis on a normal template, in which X is replaced by T (Fig. 3B) . As expected, the predominant reaction for pol III and pol II is the incorporation of dAMP opposite T when dATP is the only substrate present. A small amount dTMP misincorporation is also occurring, possibly by a transient misalignment mechanism involving the downstream template A (31). In the case of UmuDЈ 2 C, either four G's, four A's, three T's, two C's, or two ribo A's are incorporated (Fig. 3B) , indicating that the mutagenic Umu complex stimulates misincorporations and mismatch extensions on natural DNA templates as well as those containing DNA damage.
Although the data in Fig. 3 appear to suggest that the nucleotide specificities revealed in the single dNTP experiments for the UmuDЈ 2 C complex is clearly distinct from either pol II or pol III, leaving open the possibility that Umu might contain a distinct polymerizing component, such altered pol specificities could also be accounted for by an alteration of pol properties while interacting with UmuDЈ 2 C. We intend to resolve this issue by studying UmuDЈ 2 C purified from polB null and polC temperature-sensitive strains.
DISCUSSION
Despite our ever-increasing understanding of the SOS response and its many repair pathways, little is known about the biochemical mechanisms of SOS mutagenesis (1, 32) . Most of our knowledge is based on genetic data which indicate that UmuC, UmuDЈ, RecA, and pol III holoenzyme are involved in SOS mutagenesis (2), perhaps as a ''mutasome'' complex (4). The basic principle underlying translesion DNA synthesis is that a replication fork stalls when encountering a DNA damage site, and that SOS-induced UmuC, UmuDЈ, and RecA* proteins interact with pol III to shepherd it past a template lesion, resulting primarily in a base substitution mutation at the lesion site (33) . The principal difficulty in investigating the biochemical basis of SOS lesion bypass stems from problems in purifying biologically active UmuC protein, which is inherently insoluble in aqueous solution when overproduced (15) .
Echols and coworkers (16) were the first to observe UmuCUmuDЈ-dependent lesion bypass by using a preparation of UmuC that was purified in a denatured state in the presence of 8 M urea and subsequently renatured (15, 24) . There were several major difficulties working with renatured UmuC, including small yields of renatured soluble protein, poor signal-to-noise in the bypass reaction, variability in the conditions for bypass: some preparations showing bypass with activated wild-type RecA protein whereas others did not (24) . Owing to uncertainties in the biological activity of refolded UmuC protein and to circumvent the problems relating to insoluble UmuC protein, we purified sizable quantities of soluble UmuC tightly complexed to UmuDЈ (17) .
Reconstitution of a UmuD 2 C-RecA-Dependent SOS Lesion Bypass System in Vitro. Lesion bypass occurs as a two-step reaction with a nucleotide initially incorporated opposite the lesion, followed by extension from a distorted primer terminus. Both steps involve aberrant synthetic reactions which pols catalyze at greatly reduced efficiencies (about 10 Ϫ4 -to 10 Ϫ5 -fold) compared with normal synthetic reactions (34, 35) .
In our in vitro system, bypass of an abasic lesion depends on the presence of UmuDЈ 2 C, RecA*, ␤-sliding clamp, ␥-clamploading complex, and SSB (Fig. 1) . When either UmuDЈ 2 C or RecA* is excluded from the reaction, synthesis terminates at the X ؊ 1 template position, one base prior to reaching the abasic lesion, X, indicating that both bypass steps require the presence of UmuDЈ 2 C and RecA* (Fig. 1, lanes 5 and 9) . A model by Bridges and Woodgate (13) posits that pol III can, by itself, incorporate a nucleotide opposite a lesion, but cannot catalyze bypass in the absence of UmuDЈ and UmuC proteins (36) . However, recent data show that replacement of umuDC by either mucAB or rumAB alters the mutational specificity at T-T cyclobutane dimers, suggesting that the UmuDЈ 2 C complex might also influence pol insertion specificities in addition to modulating bypass (37) .
Requirement for RecA*, SSB, and ␤,␥-Complex During Lesion Bypass. RecA protein plays a direct role in catalyzing SOS mutagenesis beyond its involvement in cleavage of LexA and UmuD proteins (7) (8) (9) 29) . Omission of wild-type RecA (Fig. 1, lanes 6 and 7) or the addition of RecA1730 (Fig. 1, lane  10) , a missense mutant refractory to Umu-dependent mutagenesis, resulted in no detectable bypass. These observations are, therefore, entirely consistent with the genetic data and lend credence to the biological relevance of the reconstitution assay.
SSB protein was also essential for bypass. Such a requirement may be indirect because SSB eliminates DNA secondary structure, keeps the ␤-clamp from sliding off linear DNA (21) , and helps RecA achieve its activated state (23) . However, because MucB, a homolog of UmuC, was shown to interact directly with SSB in a yeast two-hybid assay (38) , perhaps lesion bypass is stimulated by a direct UmuC-SSB interaction. A requirement for ␤,␥-complex in the bypass assay might be to increase the residence time of the mutasome at the lesion site.
UmuD 2 C-Stimulated Lesion Bypass in the Presence of Pol III and Pol II. Although our preparation of UmuDЈ 2 C appears to be Ͼ95% pure, we nevertheless observed significant primer elongation in the absence of exogeneous DNA pol (Fig. 1 , UmuDЈ 2 C). Optimal lesion bypass on the M13 DNA template requires the presence of a 100-fold molar excess UmuDЈ 2 C (200 nM UmuDЈ 2 C: 2 nM p͞t DNA). We determined that the rate of DNA synthesis observed with UmuDЈ 2 C corresponds to about 1 nM pol III core or less than 0.2 nM pol II (Fig. 3B, lanes  4) . Thus, contamination of UmuDЈ 2 C with 0.5% pol III core or Ͻ0.1% pol II, minute levels which would not show up on either Coomassie or silver-stained polyacrylamide gels, could account for DNA synthesis in the absence of exongenous pol. Contamination with pol I was ruled out by using a potent pol I neutralizing antibody. It is unlikely that UmuDЈ 2 C is bound to either pol III, pol III ␣-subunit, or pol II, because the Umu complex migrates with its expected molecular mass of 70 kDa based on Sephadex gel filtration in 1 M salt (17) .
The weak, possibly adventitious, pol activity was titrated out by adding a large excess of purified pol in the assay, enabling us to examine the effect of UmuDЈ 2 C-stimulated bypass in the presence of pol III or pol II. By using up to a 20-fold excess of pol III core and pol II, we determined that the percentage of lesion bypass actually decreased by about a factor of two with increasing pol III activities (Fig. 2) , attributable to proofreading at the lesion site and at a site one base downstream from the lesion. Despite the decrease in the percentage of lesion bypass with increasing concentrations of pol III core and pol II, there is a marked increase in the synthesis of intermediateand full-length product DNA (Fig. 2) , suggesting that pol III core or pol II can bind to primers that have been extended past the lesion for continued synthesis along an undamaged region of the template.
The principal conclusion to be drawn from the pol titration measurements is that both lesion bypass reactions, incorporation opposite the lesion and extension past the lesion, are determined by the action of the UmuDЈ 2 C and RecA* proteins, rather than by pol III, ␣-subunit, or pol II, because lesion bypass is reduced significantly for each pol in the absence of UmuDЈ 2 C (Fig. 2) . Conversely, when the concentration of UmuDЈ 2 C is varied at a fixed pol concentration, the efficiency of bypass increases, reaching a maximum value at a ratio of about 100 UmuDЈ 2 C to 1 p͞t DNA. Effects of UmuD 2 C on DNA Synthesis Fidelity and Processivity. Synthesis on undamaged DNA before encountering a lesion is stimulated in the presence of UmuDЈ 2 C and RecA* (Fig. 1) . However, in contrast to processive synthesis carried out by pol III core plus ␤,␥-complex, synthesis in the presence of UmuDЈ 2 C is distributive both upstream and downstream from the site of the lesion either in the presence or absence of exogenous pol III core (Fig. 1) .
Perhaps the most noteworthy property of UmuDЈ 2 C is reflected in its ability to stimulate nucleotide misincorporation and mismatch extension at aberrant and normal template sites. This property is illustrated vividly in an experiment in which just a single dNTP is present for incorporation at an abasic site (Fig. 3A) or at a normal T (replacing the abasic site), in the same sequence context (Fig. 3B) . UmuDЈ 2 C stimulates incorporation of each dNTP substrate opposite the lesion (including incorporation of riboA), and causes multiple misincorporations downstream from the the lesion, whereas pol III core and pol II catalyze negligible incorporation either at the abasic site or beyond (Fig. 3A) . In a similar vein, UmuDЈ 2 C stimulates misincorporations opposite a normal template T site and beyond, whereas pol III core and pol II predominantly incorporate only A opposite T (Fig. 3B) .
These data illustrate how the Umu complex can be involved in both SOS-targeted and untargeted mutagenesis. In the case of mutagenesis targeted to the site of a lesion, UmuDЈ 2 C causes a reduction in polymerization fidelity leading to an increase in misincorporation opposite the lesion and to a stimulation of extension past the lesion by using an aberrant primer teminus. In a recent study, it was demonstrated that SOS-dependent spontaneous mutator activity reflects the processing of replication errors containing normal bases, rather than errors opposite cryptic lesions (39) . Indeed, extension of natural base mispairs occurs with efficiencies of about 10 Ϫ4 to 10 Ϫ5 compared with extension of correctly matched base pairs (40, 41) , and thus presents a strong kinetic block to further elongation. Therefore, the role of the UmuDЈ 2 C proteins in SOS mutagenesis may be to serve as generalized ''elongation'' factors that are used by the cell to extend any kinetically unfavorable primer terminus junction, not just those at a DNA lesion.
